Clinical Trials Arena July 4, 2024
The trial found that the company’s AI platform saw success over the industry standard GPT-4 when it came to selecting patients for clinical trials.
Clinical artificial intelligence (AI) firm, Mendel, has announced results from a trial that found its Neuro-Symbolic system can outperform current systems such as GPT-4 in sorting patient cohorts from electronic medical records (EMR).
Titled ‘ACR: A Benchmark for Automatic Cohort Retrieval’ and conducted alongside Cornell University, the report found that the fact that Mendel’s AI system could outperform the industry standard of GPT4 “highlights the potential of integrating expert knowledge with language learning models (LLM) in healthcare.”
Mendel says that its AI approach couples LLMs with a proprietary hypergraph reasoning engine that can sort through patient...
Today's Sponsors
Today's Sponsor